FDAsafety guidance72% confidence
FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss
Source: FDA
Why This Matters
Why this matters: illustrates how regulators handled a comparable safety guidance decision relevant to regulatory agencies.
Regulatory Analysis
Supporting Context
- Therapeutic area
- Hepatology · Herbal Medicine
- Sub-indication
- General
Related signal: Concerns Raised Over Hepatotoxicity of Epimedium brevicornu Maxim.